P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Poster Presentation

P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

	Abstract	Full	Pdf
Dec 2019	0	1	0
Jan 2020	0	3	1
Feb 2020	0	3	1
May 2020	0	4	0
Jun 2020	0	7	0
Jul 2020	0	6	0
Sep 2020	0	7	0
Oct 2020	0	1	0
Nov 2020	0	1	0
Dec 2020	0	1	0
Jan 2021	0	1	0
Feb 2021	0	0	1
Apr 2021	0	6	0
May 2021	0	2	2
Jun 2021	0	3	0
Jul 2021	0	2	0
Sep 2021	0	3	0
Oct 2021	0	6	2
Nov 2021	0	5	4
Dec 2021	0	3	0
Jan 2022	0	4	0
Feb 2022	0	1	0
Mar 2022	0	2	1
Apr 2022	0	1	0
May 2022	0	6	0
Jun 2022	0	6	1
Jul 2022	0	9	2
Aug 2022	0	3	0
Sep 2022	0	3	0
Oct 2022	0	2	2
Nov 2022	0	3	2
Dec 2022	0	5	0
Jan 2023	0	4	1
Feb 2023	0	3	1
May 2023	0	0	2
Jul 2023	0	1	3
Aug 2023	0	0	1
Sep 2023	0	2	1
Oct 2023	0	1	1
Nov 2023	0	2	2
Dec 2023	0	3	2
Jan 2024	0	1	0
Feb 2024	0	7	2
Mar 2024	0	6	92
Apr 2024	0	8	6
May 2024	0	3	4
Jun 2024	0	1	0
Jul 2024	0	12	4
Aug 2024	0	6	0
Total	0	170	141